Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1990;16:252-260

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, M. A.
Right arrow Articles by Korner, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, M. A.
Right arrow Articles by Korner, P. I.

Hypertension, Vol 16, 252-260, Copyright © 1990 by American Heart Association


ARTICLES

Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats [published erratum appears in Hypertension 1991 Feb;17(2):262]

MA Adams, A Bobik and PI Korner
Baker Medical Research Institute, Melbourne, Australia.

Three groups of spontaneously hypertensive rats (SHR) were given enalapril (25 mg/kg/day) from 4 to 9 weeks, 4 to 14 weeks, and 14 to 20 weeks of age. The drug was stopped and observations continued for another 16-21 weeks. At selected times, we measured blood pressure, in vitro hindquarter vascular resistance properties, left ventricular weight/body weight ratio, and skeletal muscle vessel norepinephrine kinetics in treated and untreated SHR and in Wistar-Kyoto (WKY) rats. At the end of each treatment period, all cardiovascular variables were close to values of WKY rats and well below those of untreated SHR, and the norepinephrine or fractional rate constant was about 25% below those levels. After enalapril was stopped, blood pressure and left ventricular weight/body weight ratio increased in parallel to levels ranging from 30% to 50% of the normal difference between untreated SHR and WKY rats. However, in SHR treated from 4 to 9 weeks and from 4 to 14 weeks of age, hindquarter resistance properties remained close to WKY rat levels for the entire observation period of 16-21 weeks after treatment, suggesting suppression of the enhanced resistance responses of SHR (amplifier properties). In SHR treated from 14 to 20 weeks of age, suppression of amplifier properties was more transient, and they redeveloped partially 5-6 weeks after cessation of therapy. When enalapril was given up to 14 weeks of age, the long-term suppression of amplifier properties was probably mainly through prevention of smooth muscle hypertrophy in resistance vessels and possibly through other mechanisms (e.g., "rarefaction").(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Behr-Roussel, D. Gorny, K. Mevel, S. Compagnie, P. Kern, V. Sivan, J. Bernabe, M. P. Bedigian, L. Alexandre, and F. Giuliano
Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R276 - R283.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Smallegange, T. M. Hale, T. L. Bushfield, and M. A. Adams
Persistent Lowering of Pressure by Transplanting Kidneys From Adult Spontaneously Hypertensive Rats Treated With Brief Antihypertensive Therapy
Hypertension, July 1, 2004; 44(1): 89 - 94.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Smallegange, R. L. Kline, and M. A. Adams
Transplantation of Enalapril-Treated Kidneys Confers Persistent Lowering of Arterial Pressure in SHR
Hypertension, November 1, 2003; 42(5): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. M. Hale, M. J. Shoichet, T. L. Bushfield, and M. A. Adams
Time Course of Vascular Structural Changes During and After Short-Term Antihypertensive Treatment
Hypertension, August 1, 2003; 42(2): 171 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. NAKAYA, H. SASAMURA, M. HAYASHI, and T. SARUTA
Temporary Treatment of Prepubescent Rats with Angiotensin Inhibitors Suppresses the Development of Hypertensive Nephrosclerosis
J. Am. Soc. Nephrol., April 1, 2001; 12(4): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. K. Hollenberg
Hypertension, Small Arteries, and Pathways for Angiotensin II Generation : "The Proper Study of Mankind is Man"
Circulation, April 11, 2000; 101(14): 1641 - 1642.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. W. Dukacz, M. A. Adams, and R. L. Kline
Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R10 - R16.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Rizzoni, E. Porteri, A. Piccoli, M. Castellano, G. Bettoni, M. L. Muiesan, G. Pasini, D. Guelfi, M. J. Mulvany, and E. A. Rosei
Effects of Losartan and Enalapril on Small Artery Structure in Hypertensive Rats
Hypertension, August 1, 1998; 32(2): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Dilley and M. I. Nataatmadja
Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats
Cardiovasc Res, April 1, 1998; 38(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Tsuchihashi, S. Kagiyama, Y. Ohya, I. Abe, and M. Fujishima
Antihypertensive Treatment and the Responsiveness to Glutamate in Ventrolateral Medulla
Hypertension, January 1, 1998; 31(1): 73 - 76.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. K. Gillies, M. Lu, H. Wang, and R. M. K. W. Lee
AT1 Receptor Antagonist Treatment Caused Persistent Arterial Functional Changes in Young Spontaneously Hypertensive Rats
Hypertension, December 1, 1997; 30(6): 1471 - 1478.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. D. Banting, K. E. Thompson, P. Friberg, and M. A. Adams
Blunted Cardiovascular Growth Induction During Prolonged Nitric Oxide Synthase Blockade
Hypertension, September 1, 1997; 30(3): 416 - 421.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Guron, M. A. Adams, B. Sundelin, and P. Friberg
Neonatal Angiotensin-Converting Enzyme Inhibition in the Rat Induces Persistent Abnormalities in Renal Function and Histology
Hypertension, January 1, 1997; 29(1): 91 - 97.
[Abstract] [Full Text]


Home page
HypertensionHome page
W. Kiowski, L. Linder, R. Nuesch, and B. Martina
Effects of Cilazapril on Vascular Structure and Function in Essential Hypertension
Hypertension, March 1, 1996; 27(3): 371 - 376.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Rizzoni, M. Castellano, E. Porteri, G. Bettoni, M. L. Muiesan, A. Cinelli, and E. A. Rosei
Effects of Low and High Doses of Fosinopril on the Structure and Function of Resistance Arteries
Hypertension, July 1, 1995; 26(1): 118 - 123.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. I. Korner and A. Bobik
Cardiovascular Development After Enalapril in Spontaneously Hypertensive and Wistar-Kyoto Rats
Hypertension, April 1, 1995; 25(4): 610 - 619.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. M. Kett, D. Alcorn, J. F. Bertram, and W. P. Anderson
Enalapril Does Not Prevent Renal Arterial Hypertrophy in Spontaneously Hypertensive Rats
Hypertension, March 1, 1995; 25(3): 335 - 342.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. B. O'Sullivan and S. B. Harrap
Resetting Blood Pressure in Spontaneously Hypertensive Rats : The Role of Bradykinin
Hypertension, February 1, 1995; 25(2): 162 - 165.
[Abstract] [Full Text]